Grundlæggende statistik
| CIK | 1756770 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Curaleaf Holdings, Inc.
SEC Filings (Chronological Order)
Denne side giver en komplet, kronologisk liste over SEC-arkiveringer, eksklusive ejerskabsregistreringer, som vi leverer andre steder.
| September 9, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September, 2025 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal |
|
| September 9, 2025 |
a2025-09x08xcuraleafxjoi Curaleaf Holdings, Inc. Investor Relations Curaleaf Joins S&P/TSX Composite Index Inclusion in Canada's benchmark index increases exposure and broadens access across North American capital markets Curaleaf becomes sole cannabis sector representative in the index after latest rebalance STAMFORD, Conn., Sept. 8, 2025 /PRNewswire/ - Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: |
|
| August 7, 2025 |
Form 52-109F2 Certification of Interim Filings Full Certificate Form 52-109F2 Certification of Interim Filings Full Certificate I, Boris Jordan, the Chief Executive Officer of the issuer, certify the following: 1. |
|
| August 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August, 2025 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Ex |
|
| August 7, 2025 |
Curaleaf Reports Second Quarter 2025 Results; Domestic Stabilization, Robust International Momentum Second quarter 2025 total revenue of $315 million Second quarter 2025 International revenue of $41 million Second quarter 2025 adjusted gross margin(1) of 49% Awarded license to operate in Turkey’s nascent medical cannabis market Stamford, Conn,. |
|
| August 7, 2025 |
Exhibit 99.2 CURALEAF HOLDINGS, INC. Condensed Interim Consolidated Financial Statements (Unaudited) As of June 30, 2025 and December 31, 2024 and For the Three and Six Months Ended June 30, 2025 and 2024 (Expressed in Thousands United States Dollars Unless Otherwise Stated) Page(s) Financial Statements: Condensed Interim Consolidated Balance Sheets (Unaudited) as of June 30, 2025 and December 31, |
|
| August 7, 2025 |
Form 52-109F2 Certification of Interim Filings Full Certificate Form 52-109F2 Certification of Interim Filings Full Certificate I, Ed Kremer, Chief Financial Officer of the issuer, certify the following: 1. |
|
| July 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July, 2025 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Exec |
|
| July 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July, 2025 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Exec |
|
| July 8, 2025 |
Curaleaf Holdings, Inc. Investor Relations Curaleaf to Report Second Quarter 2025 Financial and Operational Results STAMFORD, Conn., July 8, 2025 /PRNewswire/ - Curaleaf Holdings, Inc. (TSX: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that it will report its financial and operating results for the second qua |
|
| July 8, 2025 |
Curaleaf Holdings, Inc. Investor Relations Curaleaf Holdings Announces Buyout of Minority Partner in Curaleaf International STAMFORD, Conn., July 8, 2025 /PRNewswire/ - Curaleaf Holdings, Inc. (TSX: CURA, OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced that it has acquired the equity stake in Curaleaf International Holdin |
|
| June 16, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June, 2025 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Exec |
|
| June 16, 2025 |
CURALEAF HOLDINGS, INC. REPORT OF VOTING RESULTS CURALEAF HOLDINGS, INC. REPORT OF VOTING RESULTS TO: British Columbia Securities Commission Alberta Securities Commission Financial and Consumer Affairs Authority of Saskatchewan Manitoba Securities Commission Ontario Securities Commission Autorité des marchés financiers (Québec) Financial and Consumer Services Commission (New Brunswick) Nova Scotia Securities Commission Financial and Consumer Ser |
|
| June 16, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June, 2025 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Exec |
|
| June 16, 2025 |
Curaleaf Appoints CPG Leader Rahul Pinto as President, Bolsters Marketing Leadership Team Rahul Pinto to lead all Global Commercial functions as Curaleaf President Leadership team strengthened by three SVP Hires across Digital, Retail Merchandising and Brand Marketing STAMFORD, CT, June 16, 2025 – Curaleaf Holdings, Inc. |
|
| June 16, 2025 |
Curaleaf Reports on Voting Results from the 2025 Annual General Meeting of Shareholders Curaleaf Reports on Voting Results from the 2025 Annual General Meeting of Shareholders STAMFORD, Conn. |
|
| May 19, 2025 |
CURALEAF HOLDINGS, INC. NOTICE OF ANNUAL GENERAL MEETING OF THE SHAREHOLDERS OF CURALEAF HOLDINGS, INC. AND MANAGEMENT INFORMATION CIRCULAR FOR THE ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD VIRTUALLY ON JUNE 13, 2025 (https://web.lumiconnect.com/262434694) April 29, 2025 CURALEAF HOLDINGS, INC. 290 Harbor Drive Stamford, CT 06902 NOTICE OF ANNUAL GENERAL MEETING OF THE SHAREHOLDERS NOTICE |
|
| May 19, 2025 |
DN: CURALEAF HOLDINGS, INC. Form of Proxy – Annual General Meeting to be held on June 13, 2025 at 9:00 a.m. (ET) Trader’s Bank Building 702, 67 Yonge Street Toronto ON M5E 1J8 Appointment of Proxyholder I/We being the undersigned holder(s) of Curaleaf Holdings, Inc. hereby appoint Boris Jordan (Chairman and Chief Executive Officer) or failing this person, Joseph Lusardi (Executive Vice-Chairman) O |
|
| May 19, 2025 |
CURALEAF HOLDINGS, INC. 290 Harbor Drive Stamford, CT 06902 NOTICE OF ANNUAL GENERAL MEETING OF THE SHAREHOLDERS NOTICE IS HEREBY GIVEN that the annual general meeting of shareholders (the “Meeting”) of Curaleaf Holdings, Inc. (the “Company”) will be held on June 13, 2025 at 9:00 a.m. (Eastern Time). This year again, the meeting will be held in a virtual format only. Our virtual annual general mee |
|
| May 19, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May, 2025 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Execu |
|
| May 9, 2025 |
Exhibit 99.2 CURALEAF HOLDINGS, INC. Condensed Interim Consolidated Financial Statements (Unaudited) As of March 31, 2025 and December 31, 2024 and For the Three Months Ended March 31, 2025 and 2024 (Expressed in Thousands United States Dollars Unless Otherwise Stated) Page(s) Financial Statements: Condensed Interim Consolidated Balance Sheets (Unaudited) as of March 31, 2025 and December 31, 2024 |
|
| May 9, 2025 |
Form 52-109F2 Certification of Interim Filings Full Certificate Form 52-109F2 Certification of Interim Filings Full Certificate I, Ed Kremer, Chief Financial Officer of the issuer, certify the following: 1. |
|
| May 9, 2025 |
Curaleaf Reports First Quarter 2025 Results First quarter 2025 total revenue of $310 million First quarter 2025 International revenue of $35 million First quarter 2025 adjusted gross margin(1) of 50% First quarter 2025 operating cash flow from continuing operations of $42 million and free cash flow from continuing operations of $26 million Stamford, Conn,. |
|
| May 9, 2025 |
Form 52-109F2 Certification of Interim Filings Full Certificate Form 52-109F2 Certification of Interim Filings Full Certificate I, Boris Jordan, the Chief Executive Officer of the issuer, certify the following: 1. |
|
| May 9, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May, 2025 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Execu |
|
| April 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April, 2025 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Exe |
|
| April 8, 2025 |
Curaleaf to Report First Quarter 2025 Financial and Operational Results Curaleaf to Report First Quarter 2025 Financial and Operational Results Stamford, CT April 7, 2025 - Curaleaf Holdings, Inc. |
|
| March 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 40-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 40-F o REGISTRATION STATEMENT PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 or x ANNUAL REPORT PURSUANT TO SECTION 13(a) OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 Commission File Number 333-249081 CURALEAF HOLDINGS, INC. (Exact name of Registrant as specifi |
|
| March 4, 2025 |
Exhibit 99.6 CERTIFICATION PURSUANT TO 18 U.S.C. §1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Curaleaf Holdings, Inc. (the “Company”) on Form 40-F for the period ended December 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Ed Kremer, Chief Financial Officer of the Company, c |
|
| March 4, 2025 |
Curaleaf Reports Fourth Quarter and Full Year 2024 Results Fourth quarter 2024 total revenue of $331 million Fourth quarter 2024 International revenue of $31 million Fourth quarter adjusted gross margin(1) of 48% Full year operating cash flow from continuing operations of $163 million and free cash flow from continuing operations of $70 million Stamford, Conn,. |
|
| March 4, 2025 |
Exhibit 99.3 CERTIFICATION I, Boris Jordan, certify that: 1.I have reviewed this annual report on Form 40-F of Curaleaf Holdings, Inc. (the “report”); 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading |
|
| March 4, 2025 |
Exhibit 99.5 CERTIFICATION PURSUANT TO 18 U.S.C. §1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Curaleaf Holdings, Inc. (the “Company”) on Form 40-F for the period ended December 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Boris Jordan, Chief Executive Officer of the Company |
|
| March 4, 2025 |
Exhibit 99.4 CERTIFICATION I, Ed Kremer, certify that: 1.I have reviewed this annual report on Form 40-F of Curaleaf Holdings, Inc. (the “report”); 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading wi |
|
| March 4, 2025 |
Exhibit 99.1 CURALEAF HOLDINGS, INC. ANNUAL INFORMATION FORM Year ended December 31, 2024 March 3, 2025 TABLE OF CONTENTS EXPLANATORY NOTES 1 CORPORATE STRUCTURE 3 BUSINESS OF THE COMPANY 9 GENERAL DEVELOPMENT OF THE BUSINESS 17 UNITED STATES REGULATORY OVERVIEW 20 RISK FACTORS 29 DIVIDENDS 55 DESCRIPTION OF THE CAPITAL STRUCTURE 56 MARKET FOR SECURITIES AND TRADING PRICE AND VOLUME 58 ESCROWED SE |
|
| March 4, 2025 |
CONSENT OF PKF O'CONNOR DAVIES, LLP Exhibit 99.7 CONSENT OF PKF O'CONNOR DAVIES, LLP We hereby consent to the incorporation by reference of: •our report, dated March 3, 2025, on the consolidated financial statements of Curaleaf Holdings, Inc. (the “Company”), which comprise the consolidated balance sheets as of December 31, 2024 and 2023 and the consolidated statements of operations, comprehensive loss, temporary equity and sharehol |
|
| March 4, 2025 |
Exhibit 99.2 CURALEAF HOLDINGS, INC. Consolidated Financial Statements As of and for the Years Ended December 31, 2024 and 2023 (Expressed in Thousands United States Dollars Unless Otherwise Stated) Page(s) Report of Independent Registered Public Accounting Firm (PCAOB ID 127) 1 Financial Statements: Consolidated Balance Sheets as of December 31, 2024 and 2023 4 Consolidated Statements of Operatio |
|
| March 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-X/A APPOINTMENT OF AGENT FOR SERVICE OF PROCESS AND UNDERTAKING A. Name of issuer or person filing ("Filer"): Curaleaf Holdings, Inc. B. (1) This is [check one]: an original filing for the Filer x an amended filing for the Filer (2) Check the following box if you are filing the Form F-X in paper in accordance with Regul |
|
| February 5, 2025 |
As filed with the Securities and Exchange Commission on February 5, 2025 As filed with the Securities and Exchange Commission on February 5, 2025 Registration No. |
|
| February 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-X APPOINTMENT OF AGENT FOR SERVICE OF PROCESS AND UNDERTAKING A. Name of issuer or person filing ("Filer"): Curaleaf Holdings, Inc. B. (1) This is [check one]: x an original filing for the Filer ¨ an amended filing for the Filer (2) Check the following box if you are filing the Form F-X in paper in accordance with Regul |
|
| February 5, 2025 |
Exhibit 7.1 CURALEAF HOLDINGS, INC. as Issuer and [ ] as U.S. Trustee and [ ] as Canadian Trustee Indenture Dated as of [ ] TABLE OF CONTENTS ARTICLE One DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 Section 1.01 Definitions 1 Section 1.02 Rules of Construction 9 Section 1.03 Compliance Certificates and Opinions 10 Section 1.04 Form of Documents Delivered to Trustees 10 Section 1.05 Ac |
|
| February 5, 2025 |
Table 1: Newly Registered Securities Calculation of Filing Fee Tables F-10 Curaleaf Holdings, Inc. Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule or Instruction Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Other Subordinate Voting Shares, Debt Securities Subscription Receipts, Warrants and Units 457(o) Fees |
|
| November 12, 2024 |
Curaleaf Secures New $40 Million Revolving Credit Facility The new revolving line of credit will support ongoing working capital needs STAMFORD, CT, November 6, 2024 – Curaleaf Holdings, Inc. |
|
| November 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November, 2024 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal |
|
| November 7, 2024 |
Form 52-109F2 Certification of Interim Filings Full Certificate Form 52-109F2 Certification of Interim Filings Full Certificate I, Ed Kremer, Chief Financial Officer of the issuer, certify the following: 1. |
|
| November 7, 2024 |
Form 52-109F2 Certification of Interim Filings Full Certificate Form 52-109F2 Certification of Interim Filings Full Certificate I, Boris Jordan, the Chief Executive Officer of the issuer, certify the following: 1. |
|
| November 7, 2024 |
Curaleaf Reports Third Quarter 2024 Results Third quarter 2024 revenue of $331 million, representing a decrease of 1% year-over-year, and adjusted gross margin(1) of 49% Third quarter International revenue increased 82% year-over-year Year to date operating cash flow from continuing operations of $119 million and free cash flow from continuing operations of $53 million Secured $40 million revolving credit facility at 7. |
|
| November 7, 2024 |
Exhibit 99.2 CURALEAF HOLDINGS, INC. Condensed Interim Consolidated Financial Statements (Unaudited) As of September 30, 2024 and December 31, 2023 and For the Three and Nine Months Ended September 30, 2024 and 2023 Page(s) Financial Statements: Condensed Interim Consolidated Balance Sheets (Unaudited) as of September 30, 2024 and December 31, 2023 3 Condensed Interim Consolidated Statements of Op |
|
| November 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November, 2024 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal |
|
| October 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October, 2024 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal E |
|
| October 8, 2024 |
Curaleaf to Report Third Quarter 2024 Financial and Operational Results Curaleaf to Report Third Quarter 2024 Financial and Operational Results STAMFORD, October 7, 2024 - Curaleaf Holdings, Inc. |
|
| September 18, 2024 |
September 18, 2024 VIA EDGAR Division of Corporation Finance Office of Life Sciences United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N. |
|
| August 9, 2024 |
Curaleaf Announces CEO Transition Board Appoints Executive Chairman Boris Jordan as Chairman and Chief Executive Officer Outgoing CEO Matt Darin to Retire but Will Stay on as Special Advisor Through Year End STAMFORD, CT, August 7, 2024 – Curaleaf Holdings, Inc. |
|
| August 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August, 2024 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Ex |
|
| August 8, 2024 |
Curaleaf Reports Second Quarter 2024 Results Second quarter 2024 revenue of $342 million, representing an increase of 2% year-over-year and adjusted gross margin(1) of 48% Second quarter International revenue increased 78% year-over-year Second quarter 2024 operating cash flow from continuing operations of $30 million and free cash flow from continuing operations of $6 million Stamford, August 7, 2024 – Curaleaf Holdings, Inc. |
|
| August 8, 2024 |
Exhibit 99.2 CURALEAF HOLDINGS, INC. Condensed Interim Consolidated Financial Statements (Unaudited) As of June 30, 2024 and December 31, 2023 and For the Three and Six Months Ended June 30, 2024 and 2023 Page(s) Financial Statements: Condensed Interim Consolidated Balance Sheets (Unaudited) as of June 30, 2024 and December 31, 2023 3 Condensed Interim Consolidated Statements of Operations (Unaudi |
|
| August 8, 2024 |
Form 52-109F2 Certification of Interim Filings Full Certificate Form 52-109F2 Certification of Interim Filings Full Certificate I, Ed Kremer, Chief Financial Officer of the issuer, certify the following: 1. |
|
| August 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August, 2024 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Ex |
|
| August 8, 2024 |
Form 52-109F2 Certification of Interim Filings Full Certificate Form 52-109F2 Certification of Interim Filings Full Certificate I, Matt Darin, the Chief Executive Officer of the issuer, certify the following: 1. |
|
| August 6, 2024 |
Curaleaf to Begin Adult-Use Sales in Ohio on August 6 Curaleaf Products will be Available to Adults 21 and Over at Licensed Dispensaries Across Ohio Curaleaf Newark to Commence Adult-Use Sales on August 6, 2024 STAMFORD, CT, August 5, 2024 – Curaleaf Holdings, Inc. |
|
| August 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August, 2024 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Ex |
|
| July 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July, 2024 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Exec |
|
| July 26, 2024 |
Curaleaf Announces New York Retail Expansion with Two New Medical Dispensaries and Adult-Use Sales at Two Existing Stores New Rochester and Syracuse locations will expand the Company’s retail footprint to six dispensaries in New York and 148 nationwide Existing Curaleaf Plattsburgh and Curaleaf Forest Hills stores will now offer co-located medical and adult-use sales STAMFORD, CT, July 25, 2024 – Curaleaf Holdings, Inc. |
|
| July 9, 2024 |
Curaleaf to Report Second Quarter 2024 Financial and Operational Results Exhibit 99.1 Curaleaf to Report Second Quarter 2024 Financial and Operational Results STAMFORD, July 3, 2024 - Curaleaf Holdings, Inc. (TSX: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that it will report its financial and operating results for the second quarter ended June 30, 2024 after market close on Aug |
|
| July 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July, 2024. Commission File Number: 333-249081 CURALEAF HOLDINGS, INC. (Exact Name of Registrant as Specified in Charter) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8 Can |
|
| June 24, 2024 |
FOR IMMEDIATE RELEASE Curaleaf Launches Hemp Derived Product Line and New Direct to Consumer Ecommerce Marketplace Portfolio will include hemp derived THC edibles and beverages from Select and Zero Proof brands, in addition to 3rd party products, setting a new industry standard for safety, reliability and quality control STAMFORD, CONNECTICUT, June 24, 2024 – Curaleaf Holdings, Inc. |
|
| June 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June, 2024 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Exec |
|
| June 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June, 2024 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Exec |
|
| June 14, 2024 |
CURALEAF HOLDINGS, INC. REPORT OF VOTING RESULTS CURALEAF HOLDINGS, INC. REPORT OF VOTING RESULTS TO: British Columbia Securities Commission Alberta Securities Commission Financial and Consumer Affairs Authority of Saskatchewan Manitoba Securities Commission Ontario Securities Commission Autorité des marchés financiers (Québec) Financial and Consumer Services Commission (New Brunswick) Nova Scotia Securities Commission Financial and Consumer Ser |
|
| June 14, 2024 |
Curaleaf Reports on Voting Results from the 2024 Annual General Meeting of Shareholders Curaleaf Reports on Voting Results from the 2024 Annual General Meeting of Shareholders NEW YORK, June 14, 2024 – The Annual General Meeting of Shareholders of Curaleaf Holdings, Inc. |
|
| May 17, 2024 |
CURALEAF HOLDINGS, INC. Voting Instruction Form – Annual General Meeting to be held on June 14, 2024 at 9:00 a.m. (ET) Trader’s Bank Building 702, 67 Yonge St. Toronto, ON M5E 1J8 Appointee(s) I/We being the undersigned holder(s) of Curaleaf Holdings, Inc. (the “Company”) hereby appoint Boris Jordan (Executive Chairman) or failing this person, Joseph Lusardi (Executive Vice-Chairman) OR Print the |
|
| May 17, 2024 |
Notice of Availability of Proxy Materials for Curaleaf Holdings Inc. Annual General Meeting Notice of Availability of Proxy Materials for Curaleaf Holdings Inc. Annual General Meeting Meeting Date and Time: June 14, 2024 at 9:00 am Eastern Time Location: Virtual Meeting via live webcast at https://web.lumiagm.com/268315222 Please be advised that the proxy materials for the above noted securityholder meeting are available for viewing and downloading online. This document provides an overv |
|
| May 17, 2024 |
CURALEAF HOLDINGS, INC. NOTICE OF ANNUAL GENERAL MEETING OF THE SHAREHOLDERS TO BE HELD ON JUNE 14, 2024 AND MANAGEMENT INFORMATION CIRCULAR May 6, 2024 118519292 CURALEAF HOLDINGS, INC. NOTICE OF ANNUAL GENERAL MEETING OF THE SHAREHOLDERS AND NOTICE OF AVAILABILITY OF MEETING MATERIALS NOTICE IS HEREBY GIVEN that the annual general meeting of the shareholders (the “Meeting”) of Curaleaf Holdings, |
|
| May 17, 2024 |
CURALEAF HOLDINGS, INC. Form of Proxy – Annual General Meeting to be held on June 14, 2024 at 9:00 a.m. (ET) Trader’s Bank Building 702, 67 Yonge St. Toronto, ON M5E 1J8 Appointment of Proxyholder I/We being the undersigned holder(s) of Curaleaf Holdings, Inc. (the “Company”) hereby appoint Boris Jordan (Executive Chairman) or failing this person, Joseph Lusardi (Executive Vice-Chairman) OR Print |
|
| May 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May, 2024 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Execu |
|
| May 10, 2024 |
Form 52-109F2 Certification of Interim Filings Full Certificate Form 52-109F2 Certification of Interim Filings Full Certificate I, Matt Darin, the Chief Executive Officer of the issuer, certify the following: 1. |
|
| May 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May, 2024 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Execu |
|
| May 10, 2024 |
Form 52-109F2 Certification of Interim Filings Full Certificate Form 52-109F2 Certification of Interim Filings Full Certificate I, Ed Kremer, Chief Financial Officer of the issuer, certify the following: 1. |
|
| May 10, 2024 |
Exhibit 99.2 CURALEAF HOLDINGS, INC. Condensed Interim Consolidated Financial Statements (Unaudited) As of March 31, 2024 and December 31, 2023 and for the Three Months Ended March 31, 2024 and 2023 (Expressed in Thousands United States Dollars Unless Otherwise Stated) Page(s) Financial Statements: Condensed Interim Consolidated Balance Sheets (Unaudited) as of March 31, 2024 and December 31, 2023 |
|
| May 10, 2024 |
Curaleaf Reports First Quarter 2024 Results First quarter 2024 revenue of $339 million, representing an increase of 2% year-over-year and adjusted gross margin(1) of 48% First quarter 2024 adjusted EBITDA(1) of $77 million, representing 23% of revenue, a 40 basis point improvement year-over-year First quarter 2024 operating cash flow from continuing operations of $46 million and free cash flow(1) of $33 million Repurchased $15 million of our December 2026 notes at a 7. |
|
| April 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April, 2024 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Exe |
|
| April 23, 2024 |
Curaleaf Completes Acquisition of Northern Green Canada Bolsters Company's Advantage in Several Key Emerging Markets, including Australia, New Zealand, Germany, Poland and the United Kingdom NEW YORK, April 22, 2024 – Curaleaf Holdings, Inc. |
|
| April 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April, 2024 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Exe |
|
| April 9, 2024 |
April 5, 2024 Filed via SEDAR+ To All Applicable Exchanges and Securities Administrators Subject: Curaleaf Holdings, Inc. |
|
| April 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April, 2024 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Exe |
|
| April 5, 2024 |
Curaleaf to Report First Quarter 2024 Financial and Operational Results Curaleaf to Report First Quarter 2024 Financial and Operational Results NEW YORK, April 4, 2024 - Curaleaf Holdings, Inc. |
|
| March 19, 2024 |
Curaleaf to Acquire Northern Green Canada to Bolster European Flower Supply Deal Provides Curaleaf Strategic Supply Chain Advantage in Key Growth Markets of Germany, Poland, U. |
|
| March 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March, 2024 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Exe |
|
| March 7, 2024 |
Curaleaf Reports Fourth Quarter and Full Year Ended 2023 Results Fourth quarter 2023 revenue of $345 million, representing an increase of 4% quarter-over-quarter. |
|
| March 7, 2024 |
Exhibit 99.3 CERTIFICATION I, Matt Darin, certify that: 1.I have reviewed this annual report on Form 40-F of Curaleaf Holdings, Inc. (the “report”); 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading w |
|
| March 7, 2024 |
Exhibit 99.2 CURALEAF HOLDINGS, INC. Consolidated Financial Statements As of and for the Years Ended December 31, 2023 and 2022 (Expressed in Thousands United States Dollars Unless Otherwise Stated) Page(s) Report of Independent Registered Public Accounting Firm (PCAOB ID 127) 1 Financial Statements: Consolidated Balance Sheets as of December 31, 2023 and 2022 4 Consolidated Statements of Operatio |
|
| March 7, 2024 |
Exhibit 99.1 CURALEAF HOLDINGS, INC. ANNUAL INFORMATION FORM Year ended December 31, 2023 March 6, 2024 TABLE OF CONTENTS EXPLANATORY NOTES 1 CORPORATE STRUCTURE 3 BUSINESS OF THE COMPANY 9 GENERAL DEVELOPMENT OF THE BUSINESS 16 UNITED STATES REGULATORY OVERVIEW 21 RISK FACTORS 29 DIVIDENDS 56 DESCRIPTION OF THE CAPITAL STRUCTURE 57 MARKET FOR SECURITIES AND TRADING PRICE AND VOLUME 59 ESCROWED SE |
|
| March 7, 2024 |
Exhibit 99.5 CERTIFICATION PURSUANT TO 18 U.S.C. §1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Curaleaf Holdings, Inc. (the “Company”) on Form 40-F for the period ended December 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Matt Darin, Chief Executive Officer of the Company, |
|
| March 7, 2024 |
CONSENT OF PKF O'CONNOR DAVIES, LLP Exhibit 99.7 CONSENT OF PKF O'CONNOR DAVIES, LLP We hereby consent to the incorporation by reference of: •our report, dated March 6, 2024, on the consolidated financial statements of Curaleaf Holdings, Inc. (the “Company”), which comprise the consolidated balance sheets as of December 31, 2023 and 2022 and the consolidated statements of operations, comprehensive loss, temporary equity and sharehol |
|
| March 7, 2024 |
Exhibit 99.4 CERTIFICATION I, Ed Kremer, certify that: 1.I have reviewed this annual report on Form 40-F of Curaleaf Holdings, Inc. (the “report”); 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading wi |
|
| March 7, 2024 |
Exhibit 99.6 CERTIFICATION PURSUANT TO 18 U.S.C. §1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Curaleaf Holdings, Inc. (the “Company”) on Form 40-F for the period ended December 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Ed Kremer, Chief Financial Officer of the Company, c |
|
| March 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 40-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 40-F o REGISTRATION STATEMENT PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 or x ANNUAL REPORT PURSUANT TO SECTION 13(a) OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 Commission File Number 333-249081 CURALEAF HOLDINGS, INC. (Exact name of Registrant as specifi |
|
| February 13, 2024 |
Curaleaf International Acquires Can4Med, Expanding Presence in Poland’s Growing Medical Cannabis Market London, February 6, 2024 – Curaleaf International (the "Company"), part of Curaleaf Holdings (TSX:CURA) and Europe's largest vertically integrated cannabis company, is pleased to announce its acquisition of Can4Med, a prominent pharmaceutical wholesaler specializing in cannabinoid medications in Poland. |
|
| February 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February, 2024 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal |
|
| February 13, 2024 |
1 Introduction We believe that our most important assets are our Team Members and our culture. |
|
| February 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February, 2024 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal |
|
| January 26, 2024 |
Curaleaf Celebrates Launch of Adult Use Sales at Hudson Valley, NY Dispensary Curaleaf Hudson Valley is the Company’s First New York Retail Location To Commence Adult Use Sales NEW YORK, January 24, 2024 – Curaleaf Holdings, Inc. |
|
| January 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January, 2024 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal E |
|
| December 19, 2023 |
Exhibit 99.3 Curaleaf Announces Fulfilment of TSX Listing Conditions and Date of Commencement of Trading on the TSX COMPANY EXECUTIVES IN TORONTO TO RING OPENING BELL ON DECEMBER 14TH NEW YORK, (December 12, 2023) – Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that it has complie |
|
| December 19, 2023 |
Curaleaf Announced Reorganization of its U.S. Operations in Connection with TSX Listing Exhibit 99.1 Curaleaf Announced Reorganization of its U.S. Operations in Connection with TSX Listing NEW YORK, December 8, 2023 – Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that, in connection with the previously announced conditional approval of the Toronto Stock Exchange (“TS |
|
| December 19, 2023 |
CERTIFICATE BUSINESS CORPORATIONS ACT Exhibit 99.4 Number: BC1018969 CERTIFICATE OF INCORPORATION BUSINESS CORPORATIONS ACT I Hereby Certify that MACCABI VENTURES INC. was incorporated under the Business Corporations Act on November 13, 2014 at 02:27 PM Pacific Time. Issued under my hand at Victoria, British Columbia On November 13, 2014 CAROL PREST Registrar of Companies Province of British Columbia Canada Mailing Address: PO Box 943 |
|
| December 19, 2023 |
CHANGE OF STATUS REPORT SECTION 11.2 OF NATIONAL INSTRUMENT 51-102 Exhibit 99.10 CHANGE OF STATUS REPORT SECTION 11.2 OF NATIONAL INSTRUMENT 51-102 TO: British Columbia Securities Commission Alberta Securities Commission Financial and Consumer Affairs Authority of Saskatchewan The Manitoba Securities Commission Ontario Securities Commission Autorité des Marchés Financiers Financial and Consumer Services Commission (New Brunswick) Nova Scotia Securities Commission |
|
| December 19, 2023 |
FORM 51-102F3 MATERIAL CHANGE REPORT Exhibit 99.9 FORM 51-102F3 MATERIAL CHANGE REPORT Item 1 Name and Address of Company Curaleaf Holdings, Inc. ("Curaleaf" or the "Company") 420 Lexington Avenue Suite 2035 New York, New York 10170-0052 Item 2 Date of Material Change December 8, 2023 Item 3 News Release A news release with respect to the nature and substance of the material change was disseminated on December 8, 2023 through prnewsw |
|
| December 19, 2023 |
Exhibit 99.5 SECOND SUPPLEMENTAL INDENTURE DATED AS OF THE 8TH DAY OF DECEMBER, 2023 BETWEEN CURALEAF hOLDINGS, INC., AS ISSUER AND ODYSSEY TRUST COMPANY, AS TRUSTEE THIS SECOND SUPPLEMENTAL INDENTURE made as of the 8th day of December, 2023 BETWEEN: CURALEAF HOLDINGS, INC., a company incorporated under the laws of the Province of British Columbia (hereinafter called the “Issuer”); AND ODYSSEY TRU |
|
| December 19, 2023 |
Exhibit 99.2 Curaleaf Begins Adult Use Wholesale Operations in New York The Company’s Select and Grassroots Brands Are Now Available at Legal Adult Use Dispensaries in the Empire State NEW YORK, Dec. 12, 2023 – Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced that it has commenced sales |
|
| December 19, 2023 |
Exhibit 99.6 - 1 - SUBSCRIPTION AGREEMENT THIS SUBSCRIPTION AGREEMENT made as of December 8, 2023 (the “Agreement Date”) between: CURALEAF, INC., a company incorporated under the laws of the state of Delaware (the “Company”) - and - LIFEBROOK INVESTMENTS LTD., an entity formed under the laws of England and Wales (the “Subscriber”). WHEREAS, in connection with the Proposed Transaction (as defined h |
|
| December 19, 2023 |
Exhibit 99.8 CURALEAF HOLDINGS, INC. and LIFEBROOK INVESTMENTS LTD. as Shareholders and Curaleaf, Inc. as the Company SHAREHOLDERS AGREEMENT December 8, 2023 TABLE OF CONTENTS Article 1 INTERPRETATION Section 1.1 Defined Terms 1 Section 1.2 References and Usage 7 Section 1.3 Headings, etc. 8 Article 2 IMPLEMENTATION OF AGREEMENT AND TERM Section 2.1 Actions in Accordance with Agreement 8 Section 2 |
|
| December 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December, 2023. Commission File Number: 333-249081 CURALEAF HOLDINGS, INC. (Exact Name of Registrant as Specified in Charter) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8 |
|
| December 19, 2023 |
Exhibit 99.7 PROTECTION AGREEMENT CURALEAF HOLDINGS, INC. - and - CURALEAF, INC. December 8, 2023 TABLE OF CONTENTS 1. Definitions 1 2. Conduct of Business of the Company 6 (a) Conduct 6 (b) Restrictions 6 (c) Obligations 10 (d) Notices 10 (e) Annual Business Plan 11 (f) Director Designation Rights 11 (g) Information Rights 11 (h) Access 12 (i) Audit 12 (j) Investigations 12 (k) Public Announcemen |
|
| December 8, 2023 |
FORM 7 MONTHLY PROGRESS REPORT Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: Curaleaf Holdings, Inc. (the “Issuer” or “Curaleaf”) Trading Symbol: CURA Number of Outstanding Listed Securities: 640,212,780 Date: December 6, 2023 This Monthly Progress Report must be posted before the opening of trading on the fifth trading day of each month. This report is not intended to replace the Issuer’s obligation to sep |
|
| December 8, 2023 |
Curaleaf Announces Receipt of Conditional Approval to List Subordinate Voting Shares on the TSX Exhibit 99.2 Curaleaf Announces Receipt of Conditional Approval to List Subordinate Voting Shares on the TSX NEW YORK, (December 7, 2023) – Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that it has received conditional approval from the Toronto Stock Exchange (the “TSX”) to list i |
|
| December 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December, 2023. Commission File Number: 333-249081 CURALEAF HOLDINGS, INC. (Exact Name of Registrant as Specified in Charter) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8 |
|
| November 13, 2023 |
Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Ed Kremer, Chief Financial Officer of the issuer, certify the following: 1. |
|
| November 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November, 2023 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal |
|
| November 13, 2023 |
CURALEAF HOLDINGS, INC. Management’s Discussion and Analysis of Financial Condition and Results of Operations For the Three and Nine Months Ended September 30, 2023 and 2022 (Expressed in Thousands United States Dollars Unless Otherwise Stated) MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022 (Amou |
|
| November 13, 2023 |
Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Matt Darin, the Chief Executive Officer of the issuer, certify the following: 1. |
|
| November 13, 2023 |
FORM 5 QUARTERLY LISTING STATEMENT FORM 5 QUARTERLY LISTING STATEMENT Name of Listed Issuer: Curaleaf Holdings, Inc. (the “Issuer”). Trading Symbol: CURA This Quarterly Listing Statement must be posted on or before the day on which the Issuer’s unaudited interim financial statements are to be filed under the Securities Act, or, if no interim statements are required to be filed for the quarter, within 60 days of the end of the Issue |
|
| November 13, 2023 |
CURALEAF HOLDINGS, INC. Unaudited Condensed Interim Consolidated Financial Statements As of and for the Three and Nine Months Ended September 30, 2023 and 2022 (Expressed in Thousands United States Dollars Unless Otherwise Stated) TABLE OF CONTENTS Page(s) Condensed Interim Consolidated Financial Statements: Condensed Interim Consolidated Balance Sheets (Unaudited) 1 Condensed Interim Consolidated |
|
| November 13, 2023 |
Curaleaf Reports Third Quarter 2023 Results Third quarter 2023 revenue of $333 million excluding $3. |
|
| November 9, 2023 |
FORM 7 MONTHLY PROGRESS REPORT Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: Curaleaf Holdings, Inc. (the “Issuer” or “Curaleaf”) Trading Symbol: CURA Number of Outstanding Listed Securities: 640,232,167 Date: November 6, 2023 This Monthly Progress Report must be posted before the opening of trading on the fifth trading day of each month. This report is not intended to replace the Issuer’s obligation to sep |
|
| November 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November, 2023. Commission File Number: 333-249081 CURALEAF HOLDINGS, INC. (Exact Name of Registrant as Specified in Charter) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8 |
|
| October 16, 2023 |
Exhibit 99.6 FORM 9 NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF LISTED SECURITIES (or securities convertible or exchangeable into listed securities1) Name of Listed Issuer: Symbol(s): Curaleaf Holdings, Inc. (the "Issuer"). CURA Date: October 11, 2023 Is this an updating or amending Notice: x Yes ¨ No If yes provide date(s) of prior Notices: August 9, 2022 and September 15, 2022. Iss |
|
| October 16, 2023 |
Curaleaf to Report Third Quarter 2023 Financial and Operational Results Exhibit 99.4 Curaleaf to Report Third Quarter 2023 Financial and Operational Results NEW YORK, October 10, 2023 - Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that it will report its financial and operating results for the third quarter ended September 30, 2023 after market close |
|
| October 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October, 2023. Commission File Number: 333-249081 CURALEAF HOLDINGS, INC. (Exact Name of Registrant as Specified in Charter) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8 |
|
| October 16, 2023 |
FORM 7 MONTHLY PROGRESS REPORT Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: Curaleaf Holdings, Inc. (the “Issuer” or “Curaleaf”) Trading Symbol: CURA Number of Outstanding Listed Securities: 631,295,673 Date: October 5, 2023 This Monthly Progress Report must be posted before the opening of trading on the fifth trading day of each month. This report is not intended to replace the Issuer’s obligation to sepa |
|
| October 16, 2023 |
Exhibit 99.2 FORM 9 NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF LISTED SECURITIES (or securities convertible or exchangeable into listed securities1) Name of Listed Issuer: Symbol(s): Curaleaf Holdings, Inc. (the "Issuer"). CURA Date: October 9, 2023 Is this an updating or amending Notice: x Yes ¨ No If yes provide date(s) of prior Notices: October 4, 2022. Issued and Outstandin |
|
| October 16, 2023 |
Curaleaf Applies to List Subordinate Voting Shares on the Toronto Stock Exchange Exhibit 99.3 Curaleaf Applies to List Subordinate Voting Shares on the Toronto Stock Exchange NEW YORK, October 10, 2023 – Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that it has filed its application to list the Company's subordinate voting shares on the Toronto Stock Exchange |
|
| October 16, 2023 |
Exhibit 99.5 FORM 9 NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF LISTED SECURITIES (or securities convertible or exchangeable into listed securities1) Name of Listed Issuer: Symbol(s): Curaleaf Holdings, Inc. (the “Issuer”). CURA Date: October 11, 2023 Is this an updating or amending Notice: x Yes ¨No If yes provide date(s) of prior Notices: October 4, 2022 and October 9, 2023. Issued and Outstandin |
|
| October 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October, 2023. Commission File Number: 333-249081 CURALEAF HOLDINGS, INC. (Exact Name of Registrant as Specified in Charter) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8 |
|
| October 11, 2023 |
FORM 8 NOTICE OF PROPOSED PROSPECTUS OFFERING Exhibit 99.4 FORM 8 NOTICE OF PROPOSED PROSPECTUS OFFERING Please complete the following: Name of Listed Issuer: Curaleaf Holdings, Inc. (the “Issuer”). Trading Symbol: CURA Date: September 28, 2023 Is this an updating or amending Notice: ¨ Yes x No If yes provide date(s) of prior Notices: . Issued and Outstanding Securities of Issuer Prior to Proposed Prospectus Offering: 631,271,153 Date of News |
|
| October 11, 2023 |
Exhibit 99.1 UNDERWRITING AGREEMENT September 28, 2023 Curaleaf Holdings, Inc. 1700, Park Place, 666 Burrard Street Vancouver, BC V6N 2X8 Attention: Matt Darin, Chief Executive Officer Ladies and Gentleman: The undersigned, Canaccord Genuity Corp. (the “Underwriter”), as sole underwriter and sole bookrunner hereby offers and agrees to purchase from Curaleaf Holdings, Inc. (the “Company”), and the |
|
| October 11, 2023 |
Exhibit 99.2 NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Curaleaf Announces Proposed Offering of Subordinate Voting Shares NEW YORK, September 27, 2023 – Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading U.S. provider of consumer products in cannabis, announced today that it is commencing a marketed off |
|
| October 11, 2023 |
Exhibit 99.6 NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Curaleaf Announces Closing of C$16 Million Underwritten Offering of Subordinate Voting Shares NEW YORK, October 3, 2023 – Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading U.S. provider of consumer products in cannabis, announced today the closing |
|
| October 11, 2023 |
FORM 6 CERTIFICATE OF COMPLIANCE Exhibit 99.5 FORM 6 CERTIFICATE OF COMPLIANCE TO: CANADIAN SECURITIES EXCHANGE (“CSE”) Curaleaf Holdings, Inc. (the “Listed Issuer”) hereby certifies to CSE that the Listed Issuer is in compliance with the requirements of applicable securities legislation (as such term is defined in National Instrument 14-101) and all Exchange Requirements (as defined in Policy 1). Date: October 3, 2023 Signed: (s |
|
| October 11, 2023 |
Exhibit 99.3 NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Curaleaf Announces C$16 Million Underwritten Offering of Subordinate Voting Shares NEW YORK, September 28, 2023 – Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading U.S. provider of consumer products in cannabis, announced today the pricing of its |
|
| September 12, 2023 |
FORM 7 MONTHLY PROGRESS REPORT Exhibit 99.10 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: Curaleaf Holdings, Inc. (the “Issuer” or “Curaleaf”). Trading Symbol: CURA Number of Outstanding Listed Securities: 631,090,343 Date: September 7, 2023 This Monthly Progress Report must be posted before the opening of trading on the fifth trading day of each month. This report is not intended to replace the Issuer’s obligation to |
|
| September 12, 2023 |
Exhibit 99.9 July 14, 2023 Filed via SEDAR CANCELLED To All Applicable Exchanges and Securities Administrators Subject: Curaleaf Holdings, Inc. (the "Issuer") Notice of Meeting and Record Date - AMENDED Dear Sir/Madam: We are pleased to confirm the following information with respect to the Issuer's upcoming meeting of securityholders: Meeting Type: Special Meeting Meeting Date: August 18, |
|
| September 12, 2023 |
CURALEAF HOLDINGS, INC. (the “Company”) NOTICE OF ABRIDGEMENT Exhibit 99.4 CURALEAF HOLDINGS, INC. (the “Company”) NOTICE OF ABRIDGEMENT TO: The Canadian Securities Regulatory Authorities in each of the Provinces and Territories of Canada RE: Abridgement of time pursuant to National Instrument 54-101 – Communication with Beneficial Owners of Securities of a Reporting Issuer (“NI 54-101”) Date: September 5, 2023 I, Peter Clateman, the Chief Legal Officer of C |
|
| September 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September, 2023. Commission File Number: 333-249081 CURALEAF HOLDINGS, INC. (Exact Name of Registrant as Specified in Charter) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X |
|
| September 12, 2023 |
Exhibit 99.2 August 21, 2023 Filed via SEDAR To All Applicable Exchanges and Securities Administrators Subject: Curaleaf Holdings, Inc. (the “Issuer”) Notice of Meeting and Record Date Dear Sir/Madam: We are pleased to confirm the following information with respect to the Issuer’s upcoming meeting of securityholders: Meeting Type: Annual General and Special Meeting Meeting Date: October 4, 2023 Re |
|
| September 12, 2023 |
Exhibit 99.5 CURALEAF HOLDINGS, INC. NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF THE SHAREHOLDERS TO BE HELD ON OCTOBER 4, 2023 AND MANAGEMENT INFORMATION CIRCULAR These materials are important and require your immediate attention. If you have questions as to how to deal with these documents or the matters to which they refer, please contact your financial, legal or other professional advisor. |
|
| September 12, 2023 |
Exhibit 99.3 CURALEAF HOLDINGS, INC. NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF THE SHAREHOLDERS AND NOTICE OF AVAILABILITY OF MEETING MATERIALS NOTICE IS HEREBY GIVEN that the annual general and special meeting of the shareholders (the “Meeting”) of Curaleaf Holdings, Inc. (the “Company”) will be held on October 4, 2023 at 9:00 a.m. (Eastern Time). This year again, the meeting will be held i |
|
| September 12, 2023 |
Exhibit 99.6 Notice of Availability of Proxy Materials for Curaleaf Holdings, Inc. Annual General and Special Meeting Meeting Date and Time: October 4, 2023 at 9:00 am Eastern Time Location: Virtual Meeting via live webcast at https://web.lumiagm.com/265315617 Please be advised that the proxy materials for the above noted securityholder meeting are available for viewing and downloading online. Thi |
|
| September 12, 2023 |
Exhibit 99.8 CURALEAF HOLDINGS, INC. Voting Instruction Form – Annual General and Special Meeting to be held on October 4, 2023 at 9:00 a.m. (ET) Trader’s Bank Building 702, 67 Yonge St. Toronto, ON M5E 1J8 Appointee(s) I/We being the undersigned holder(s) of Curaleaf Holdings, Inc. the (“Company“) hereby appoint Boris Jordan (Executive Chairman) or failing this person, Joseph Lusardi (Executive V |
|
| September 12, 2023 |
FORM 11 NOTICE OF PROPOSED STOCK OPTION GRANT OR AMENDMENT Exhibit 99.1 FORM 11 NOTICE OF PROPOSED STOCK OPTION GRANT OR AMENDMENT Name of Listed Issuer: Curaleaf Holdings, Inc. (the “Issuer”). Trading Symbol: CURA Date: August 31, 2023 1. New Options Granted: Date of Grant: See below table Name of Optionee Position (Director/ Officer/ Employee/ Consultant/ Management Company Insider Yes or No? No. of Optioned Shares Exercise Price Expiry Date No. of Opti |
|
| September 12, 2023 |
Exhibit 99.7 CURALEAF HOLDINGS, INC. Form of Proxy – Annual General and Special Meeting to be held on October 4, 2023 at 9:00 a.m. (ET) Trader’s Bank Building 702, 67 Yonge St. Toronto, ON M5E 1J8 Appointment of Proxyholder I/We being the undersigned holder(s) of Curaleaf Holdings, Inc. (the “Company”) hereby appoint Boris Jordan (Executive Chairman) or failing this person, Joseph Lusardi (Executi |
|
| August 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August, 2023 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Ex |
|
| August 14, 2023 |
FORM 7 MONTHLY PROGRESS REPORT FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: Curaleaf Holdings, Inc. (the “Issuer” or “Curaleaf”). Trading Symbol: CURA Number of Outstanding Listed Securities: 630,938,502 Date: August 7, 2023 This Monthly Progress Report must be posted before the opening of trading on the fifth trading day of each month. This report is not intended to replace the Issuer’s obligation to separately report |
|
| August 10, 2023 |
Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Ed Kremer, Chief Financial Officer of the issuer, certify the following: 1. |
|
| August 10, 2023 |
Curaleaf Reports Second Quarter 2023 Results Second quarter 2023 revenue of $339 million, representing an increase of 4% year-over-year, and adjusted EBITDA(1) of $70 million Second quarter 2023 operating cash flow from continuing operations of $16 million and free cash flow from continuing operations(1) of $8 million NEW YORK, August 9, 2023 – Curaleaf Holdings, Inc. |
|
| August 10, 2023 |
CURALEAF HOLDINGS, INC. Unaudited Condensed Interim Consolidated Financial Statements As of and for the Three and Six Months Ended June 30, 2023 and 2022 (Expressed in Thousands United States Dollars Unless Otherwise Stated) TABLE OF CONTENTS Page(s) Condensed Interim Consolidated Financial Statements: Condensed Interim Consolidated Balance Sheets 1 Condensed Interim Consolidated Statements of Ope |
|
| August 10, 2023 |
Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Matt Darin, the Chief Executive Officer of the issuer, certify the following: 1. |
|
| August 10, 2023 |
CURALEAF HOLDINGS, INC. Management’s Discussion and Analysis of Financial Condition and Results of Operations For the Three and Six Months Ended June 30, 2023 and 2022 (Expressed in Thousands United States Dollars Unless Otherwise Stated) MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2023 AND 2022 (Amounts in thous |
|
| August 10, 2023 |
FORM 5 QUARTERLY LISTING STATEMENT FORM 5 QUARTERLY LISTING STATEMENT Name of Listed Issuer: Curaleaf Holdings, Inc. (the “Issuer”). Trading Symbol: CURA This Quarterly Listing Statement must be posted on or before the day on which the Issuer’s unaudited interim financial statements are to be filed under the Securities Act, or, if no interim statements are required to be filed for the quarter, within 60 days of the end of the Issue |
|
| August 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August, 2023 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Ex |
|
| August 9, 2023 |
Exhibit 99.1 July 14, 2023 Filed via SEDAR To All Applicable Exchanges and Securities Administrators Subject: Curaleaf Holdings, Inc. (the "Issuer") Notice of Meeting and Record Date - AMENDED Dear Sir/Madam: We are pleased to confirm the following information with respect to the Issuer's upcoming meeting of securityholders: Meeting Type: Special Meeting Meeting Date: August 18, 2023 Record Date f |
|
| August 9, 2023 |
NOTICE OF MEETING OF NOTEHOLDERS TO BE HELD ON AUGUST 18, 2023 Exhibit 99.2 NOTICE OF MEETING OF NOTEHOLDERS TO BE HELD ON AUGUST 18, 2023 NOTICE IS HEREBY GIVEN that a meeting (the “Meeting”) of the holders (the “Holders”) of Curaleaf Holdings, Inc.’s (the “Company”) 8.00% Senior Secured Notes due December 15, 2026 (the “Notes”) will be held on August 18, 2023 at 9:00 a.m. (New York time) at 420 Lexington Ave, Suite 2035, New York, New York, United States of |
|
| August 9, 2023 |
Exhibit 99.5 CURALEAF HOLDINGS, INC. CONSENT AND PROXY FORM FOR HOLDERS OF 8.0% SENIOR SECURED NOTES DUE 2026 OF CURALEAF HOLDINGS, INC. ISSUED UNDER THE TRUST INDENTURE DATED DECEMBER 15, 2021, AS SUPPLEMENTED Pursuant to the Consent and Proxy Solicitation Statement dated July 14, 2023 Consent and Proxy for the Meeting to be held on August 18, 2023 Please return this Consent and Proxy Form to the |
|
| August 9, 2023 |
Exhibit 99.4 These materials are important and require your immediate attention. They require Holders (as defined below) to make important decisions. If you are in doubt as to what decision to make, please contact your financial, legal, income tax and/or other professional advisors. If you have any questions, or require assistance with delivering your consent, please contact the Company, by email |
|
| August 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August, 2023. Commission File Number: 333-249081 CURALEAF HOLDINGS, INC. (Exact Name of Registrant as Specified in Charter) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8 C |
|
| August 9, 2023 |
CURALEAF HOLDINGS, INC. NOTICE OF ABRIDGEMENT Exhibit 99.3 CURALEAF HOLDINGS, INC. NOTICE OF ABRIDGEMENT July 14, 2023 RE: Meeting of the holders of senior secured notes due 2026 of Curaleaf Holdings, Inc. to be held on August 18, 2023 (the “Meeting”) I, Peter Clateman, the Chief Legal Officer of Curaleaf Holdings, Inc. hereby certify that: (a) arrangements have been made to have proxy related materials for the Meeting sent in compliance with |
|
| July 19, 2023 |
Curaleaf to Report Second Quarter 2023 Financial and Operational Results Curaleaf to Report Second Quarter 2023 Financial and Operational Results NEW YORK, July 12, 2023 – Curaleaf Holdings, Inc. |
|
| July 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July, 2023 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Exec |
|
| July 10, 2023 |
Curaleaf Holdings, Inc. Announcement Regarding Market Exhibit 99.5 Curaleaf Holdings, Inc. Announcement Regarding Market Rumors NEW YORK, July 7, 2023 /CNW/ - At the request of IIROC, Curaleaf Holdings, Inc. ("Curaleaf" or the "Company") (CSE: CURA) today responds to speculation published in the media regarding the possibility of a transaction involving the Company. The Company's policy is to refrain from commenting on market rumors. The Company does |
|
| July 10, 2023 |
Exhibit 99.4 Curaleaf Holdings, Inc. Investor Relations Curaleaf International Subsidiary to Acquire Clever Leaves' EU-GMP Certified Processing Facility in Portugal Deal Will Significantly Expand Flower Processing Capacity, Providing Competitive Advantage in Rapidly Growing EU Market LONDON, July 5, 2023 /PRNewswire/ - Curaleaf International (the "Company"), part of Curaleaf Holdings (CSE:CURA) an |
|
| July 10, 2023 |
Curaleaf Holdings, Inc. Announcement Regarding Market Exhibit 99.6 Curaleaf Holdings, Inc. Announcement Regarding Market Rumors NEW YORK, July 7, 2023 /CNW/ - At the request of the Canadian Investment Regulatory Organization, and following its previous announcement, Curaleaf Holdings, Inc. ("Curaleaf" or the "Company") (CSE: CURA) today responds to speculation regarding the possibility of a transaction involving the Company. As previously disclosed, |
|
| July 10, 2023 |
FORM 7 MONTHLY PROGRESS REPORT Exhibit 99.7 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: Curaleaf Holdings, Inc. (the “Issuer” or “Curaleaf”). Trading Symbol: CURA Number of Outstanding Listed Securities: 630,870,423 Date: July 9, 2023 This Monthly Progress Report must be posted before the opening of trading on the fifth trading day of each month. This report is not intended to replace the Issuer’s obligation to separa |
|
| July 10, 2023 |
All Four Curaleaf Dispensaries in Maryland Will Begin Adult Use Sales on July 1 Exhibit 99.3 Curaleaf Holdings, Inc. Investor Relations Curaleaf Celebrates Launch of Adult Use Cannabis Sales in Maryland All Four Curaleaf Dispensaries in Maryland Will Begin Adult Use Sales on July 1 NEW YORK, June 29, 2023 /PRNewswire/ - Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, announces it |
|
| July 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July, 2023. Commission File Number: 333-249081 CURALEAF HOLDINGS, INC. (Exact Name of Registrant as Specified in Charter) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8 Can |
|
| July 10, 2023 |
Exhibit 99.1 FORM 9 NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF LISTED SECURITIES (or securities convertible or exchangeable into listed securities1) Name of Listed Issuer: Symbol(s): Curaleaf Holdings, Inc. (the "Issuer") CURA Date: June 29, 2023 Is this an updating or amending Notice: x Yes ¨ No If yes provide date(s) of prior Notices: March 16, 2021 and April 7, 2021. Issued |
|
| July 10, 2023 |
Exhibit 99.2 FORM 51-102F6V STATEMENT OF EXECUTIVE COMPENSATION – VENTURE ISSUERS FOR THE YEAR ENDED DECEMBER 31, 2022 The information contained in this statement of executive compensation (the "Statement") of Curaleaf Holdings, Inc. (the "Company" or "Curaleaf"), unless otherwise indicated, is as of June 30, 2023. The information contained in this Statement is expressed in United States dollars, |
|
| June 16, 2023 |
EX-99.1 2 cseform9-deseretwellness11.htm EX-99.1 FORM 9 NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF LISTED SECURITIES (or securities convertible or exchangeable into listed securities) Name of Listed Issuer: Symbol(s): Curaleaf Holdings, Inc. (the “Issuer”). CURA Date: June 12, 2023 Is this an updating or amending Notice: Yes No If yes provide date(s) of prior Notices: March 30, 2023 and April 5, 2 |
|
| June 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June, 2023 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Exec |
|
| June 8, 2023 |
FORM 7 MONTHLY PROGRESS REPORT FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: Curaleaf Holdings, Inc. (the “Issuer” or “Curaleaf”). Trading Symbol: CURA Number of Outstanding Listed Securities: 624,719,285 Date: June 6, 2023 This Monthly Progress Report must be posted before the opening of trading on the fifth trading day of each month. This report is not intended to replace the Issuer’s obligation to separately report m |
|
| June 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June, 2023 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Exec |
|
| May 18, 2023 |
Curaleaf Reports First Quarter 2023 Results First quarter 2023 revenue of $336.5 million, representing an increase of 14% year-over-year, and adjusted EBITDA(1) of $73.2 million Operating cash flow from continuing operations of $30.6 million and cash on balance sheet of $115.8 million NEW YORK, May 17, 2023 – Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leadi |
|
| May 18, 2023 |
Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Ed Kremer, Chief Financial Officer of the issuer, certify the following: 1. |
|
| May 18, 2023 |
CURALEAF HOLDINGS, INC. Management’s Discussion and Analysis of Financial Condition and Results of Operations As of and for the Three Months Ended March 31, 2023 and 2022 (Expressed in Thousands United States Dollars Unless Otherwise Stated) 1 MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED MARCH 31, 2023 AND 2022 (Amounts in thousan |
|
| May 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May, 2023 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Execu |
|
| May 18, 2023 |
FORM 5 QUARTERLY LISTING STATEMENT FORM 5 QUARTERLY LISTING STATEMENT Name of Listed Issuer: Curaleaf Holdings, Inc. (the “Issuer”). Trading Symbol: CURA This Quarterly Listing Statement must be posted on or before the day on which the Issuer’s unaudited interim financial statements are to be filed under the Securities Act, or, if no interim statements are required to be filed for the quarter, within 60 days of the end of the Issue |
|
| May 18, 2023 |
CURALEAF HOLDINGS, INC. Unaudited Condensed Interim Consolidated Financial Statements As of and for the Three Months Ended March 31, 2023 and 2022 (Expressed in Thousands United States Dollars Unless Otherwise Stated) Page(s) Condensed Interim Consolidated Financial Statements Condensed Interim Consolidated Balance Sheets 1 Condensed Interim Consolidated Statements of Operations (Unaudited) 2 Cond |
|
| May 18, 2023 |
Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Matt Darin, the Chief Executive Officer of the issuer, certify the following: 1. |
|
| May 5, 2023 |
FORM 7 MONTHLY PROGRESS REPORT Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT Name of Listed Issuer: Curaleaf Holdings, Inc. (the “Issuer” or “Curaleaf”). Trading Symbol: CURA Number of Outstanding Listed Securities: 624,690,068 Date: May 4, 2023 This Monthly Progress Report must be posted before the opening of trading on the fifth trading day of each month. This report is not intended to replace the Issuer’s obligation to separat |
|
| May 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May, 2023. Commission File Number: 333-249081 CURALEAF HOLDINGS, INC. (Exact Name of Registrant as Specified in Charter) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8 Cana |
|
| May 5, 2023 |
Curaleaf Holdings, Inc. Investor Relations Exhibit 99.2 Curaleaf Holdings, Inc. Investor Relations Curaleaf to Report First Quarter 2023 Financial and Operational Results NEW YORK, May 5, 2023 / PRNewswire/ - Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer products in cannabis, today announced that it will report its financial and operating results for the first |
|
| May 3, 2023 |
Curaleaf Reports Fourth Quarter and Fiscal Year End 2022 Results EX-99.1 2 tm2314443d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Curaleaf Reports Fourth Quarter and Fiscal Year End 2022 Results · Record fiscal year 2022 revenue of $1.34 billion and Adjusted EBITDA(1) of $305 million, representing an increase of 12% and 17% from fiscal 2021, respectively · Fourth quarter 2022 Revenue of $352.5 million, representing an increase of 14% year-over-year, and Adjusted EBITD |
|
| May 3, 2023 |
Exhibit 99.4 CERTIFICATION I, Matt Darin, certify that: 1. I have reviewed this Amendment No. 1 to annual report on Form 40-F of Curaleaf Holdings, Inc. (the “report”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were m |
|
| May 3, 2023 |
Exhibit 99.6 CERTIFICATION PURSUANT TO 18 U.S.C. §1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Amendment No. 1 to Annual Report of Curaleaf Holdings, Inc. (the “Company”) on Form 40-F for the period ended December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Matt Darin, Chief Executive Offic |
|
| May 3, 2023 |
CONSENT OF ANTARES PROFESSIONAL CORPORATION Exhibit 99.9 CONSENT OF ANTARES PROFESSIONAL CORPORATION We hereby consent to the incorporation by reference of: ● our report, dated May 1, 2023, on the consolidated financial statements of the Curaleaf Holdings, Inc. (the “Company”) and its subsidiaries, which comprise the consolidated balance sheet as at December 31, 2021 and the consolidated statements of operations, comprehensive income (loss) |
|
| May 3, 2023 |
Exhibit 99.5 CERTIFICATION I, Ed Kremer, certify that: 1. I have reviewed this Amendment No. 1 to annual report on Form 40-F of Curaleaf Holdings, Inc. (the “report”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were ma |
|
| May 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 40-F/A Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 40-F/A Amendment No. 1 ☐REGISTRATION STATEMENT PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 or ☒ANNUAL REPORT PURSUANT TO SECTION 13(a) OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 Commission File Number 333-249081 CURALEAF HOLDINGS, INC. (Exact name of Regis |
|
| May 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May, 2023. Commission File Number: 333-249081 CURALEAF HOLDINGS, INC. (Exact Name of Registrant as Specified in Charter) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8 Cana |
|
| May 3, 2023 |
Exhibit 99.2 CURALEAF HOLDINGS, INC. Consolidated Financial Statements As of and for the Years Ended December 31, 2022 and 2021 (Expressed in Thousands United States Dollars Unless Otherwise Stated) Notice to Reader The Company has chosen to prepare its financial statements filed on SEDAR and EDGAR in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) begin |
|
| May 3, 2023 |
CONSENT OF PKF O'CONNOR DAVIES, LLP Exhibit 99.8 CONSENT OF PKF O'CONNOR DAVIES, LLP We hereby consent to the incorporation by reference of: ● our report, dated May 1, 2023, on the consolidated financial statements of the Curaleaf Holdings, Inc. (the “Company”) and its subsidiaries, which comprise the consolidated balance sheet as at December 31, 2022 and the consolidated statements of operations, comprehensive income (loss), shareh |
|
| May 3, 2023 |
Exhibit 99.7 CERTIFICATION PURSUANT TO 18 U.S.C. §1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Amendment No. 1 to Annual Report of Curaleaf Holdings, Inc. (the “Company”) on Form 40-F for the period ended December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Ed Kremer, Chief Financial Office |
|
| May 2, 2023 |
Form 52-109F2R Certification of Refiled Interim Filings Exhibit 99.4 Form 52-109F2R Certification of Refiled Interim Filings This certificate is being filed on the same date that Curaleaf Holdings, Inc. (the “issuer”) has refiled interim financial report and interim MD&A for the interim period ended March 31, 2022 presented under US GAAP. I, Ed Kremer, Chief Financial Officer of the issuer, certify the following: 1. Review: I have reviewed the interim |
|
| May 2, 2023 |
EX-99.5 5 curlf-20211231xex99d5.htm EX-99.5 Exhibit 99.5 CERTIFICATION I, Ed Kremer, certify that: 1. I have reviewed this Amendment No. 1 to annual report on Form 40-F of Curaleaf Holdings, Inc. (the “report”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circu |
|
| May 2, 2023 |
Exhibit 99.4 CERTIFICATION I, Matt Darin, certify that: 1. I have reviewed this Amendment No. 1 to annual report on Form 40-F of Curaleaf Holdings, Inc. (the “report”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were m |
|
| May 2, 2023 |
Form 52-109F2R Certification of Refiled Interim Filings Exhibit 99.3 Form 52-109F2R Certification of Refiled Interim Filings This certificate is being filed on the same date that Curaleaf Holdings, Inc. (the “issuer”) has refiled interim financial report and interim MD&A for the interim period ended March 31, 2022 presented under IFRS. I, Matt Darin, Chief Executive Officer of the issuer, certify the following: 1. Review: I have reviewed the interim fi |
|
| May 2, 2023 |
Exhibit 99.2 CURALEAF HOLDINGS, INC. Amended and Restated Management’s Discussion and Analysis of Financial Condition and Results of Operations As of and for the Three and Nine Months Ended September 30, 2022 and 2021 As Amended and Restated (Expressed in Thousands United States Dollars Unless Otherwise Stated) Notice to Reader Curaleaf Holdings, Inc. (the “Company”, "Curaleaf" or the "Group") has |
|
| May 2, 2023 |
Form 52-109F2R Certification of Refiled Interim Filings Exhibit 99.12 Form 52-109F2R Certification of Refiled Interim Filings This certificate is being filed on the same date that Curaleaf Holdings, Inc. (the “issuer”) has refiled interim financial report and interim MD&A for the interim period ended September 30, 2022 presented under US GAAP. I, Ed Kremer, Chief Financial Officer of the issuer, certify the following: 1. Review: I have reviewed the int |
|
| May 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K/A (Amendment No. 1) REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May, 2023. Commission File Number: 333-249081 CURALEAF HOLDINGS, INC. (Exact Name of Registrant as Specified in Charter) 666 Burrard Street, Suite 1700, Vancouver, British C |
|
| May 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 40-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 40-F ☐REGISTRATION STATEMENT PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 or ☒ANNUAL REPORT PURSUANT TO SECTION 13(a) OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 Commission File Number 333-249081 CURALEAF HOLDINGS, INC. (Exact name of Registrant as specified |
|
| May 2, 2023 |
Form 52-109F2R Certification of Refiled Interim Filings Exhibit 99.4 Form 52-109F2R Certification of Refiled Interim Filings This certificate is being filed on the same date that Curaleaf Holdings, Inc. (the “issuer”) has refiled interim financial report and interim MD&A for the interim period ended March 31, 2022 presented under IFRS. I, Ed Kremer, Chief Financial Officer of the issuer, certify the following: 1. Review: I have reviewed the interim fin |
|
| May 2, 2023 |
Exhibit 99.2 CURALEAF HOLDINGS, INC. Amended and Restated Management’s Discussion and Analysis of Financial Condition and Results of Operations As of and for the Three and Six Months Ended June 30, 2022 and 2021 As Amended and Restated (Expressed in Thousands United States Dollars Unless Otherwise Stated) Notice to Reader Curaleaf Holdings, Inc. (the “Company”, "Curaleaf" or the "Group") has resta |
|
| May 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K/A (Amendment No. 1) REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May, 2023. Commission File Number: 333-249081 CURALEAF HOLDINGS, INC. (Exact Name of Registrant as Specified in Charter) 666 Burrard Street, Suite 1700, Vancouver, British C |
|
| May 2, 2023 |
CONSENT OF ANTARES PROFESSIONAL CORPORATION Exhibit 99.8 CONSENT OF ANTARES PROFESSIONAL CORPORATION We hereby consent to the incorporation by reference of: ● our report, dated May 1, 2023, on the consolidated financial statements of the Curaleaf Holdings, Inc. (the “Company”) and its subsidiaries, which comprise the consolidated statements of financial position as at December 31, 2021 and December 31, 2020, and the consolidated statements |
|
| May 2, 2023 |
EX-99.6 6 curlf-20211231xex99d6.htm EX-99.6 Exhibit 99.6 CERTIFICATION PURSUANT TO 18 U.S.C. §1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Amendment No. 1 to Annual Report of Curaleaf Holdings, Inc. (the “Company”) on Form 40-F for the period ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Re |
|
| May 2, 2023 |
Exhibit 99.4 CERTIFICATION I, Matt Darin, certify that: 1. I have reviewed this annual report on Form 40-F of Curaleaf Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect t |
|
| May 2, 2023 |
Form 52-109F2R Certification of Refiled Interim Filings Exhibit 99.3 Form 52-109F2R Certification of Refiled Interim Filings This certificate is being filed on the same date that Curaleaf Holdings, Inc. (the “issuer”) has refiled interim financial report and interim MD&A for the interim period ended September 30, 2022 presented under IFRS. I, Matt Darin, Chief Executive Officer of the issuer, certify the following: 1. Review: I have reviewed the interi |
|
| May 2, 2023 |
Exhibit 99.9 CURALEAF HOLDINGS, INC. Amended and Restated Unaudited Condensed Interim Consolidated Financial Statements As of and for the Three and Nine Months Ended September 30, 2022 and 2021 (Expressed in Thousands United States Dollars Unless Otherwise Stated) Notice to Reader Curaleaf Holdings, Inc. (the “Company”, “Curaleaf” or the “Group”) now prepares its financial statements filed with th |
|
| May 2, 2023 |
Exhibit 99.2 CURALEAF HOLDINGS, INC. Consolidated Financial Statements As of and for the Years Ended December 31, 2021 and 2020 As Amended and Restated (Expressed in Thousands United States Dollars Unless Otherwise Stated) Notice to Reader Curaleaf Holdings, Inc. (the “Company”, "Curaleaf" or the "Group") has restated its audited annual consolidated financial statements for the three and twelve mo |
|
| May 2, 2023 |
Form 52-109F2R Certification of Refiled Interim Filings Exhibit 99.11 Form 52-109F2R Certification of Refiled Interim Filings This certificate is being filed on the same date that Curaleaf Holdings, Inc. (the “issuer”) has refiled interim financial report and interim MD&A for the interim period ended September 30, 2022 presented under US GAAP. I, Matt Darin, Chief Executive Officer of the issuer, certify the following: 1. Review: I have reviewed the in |
|
| May 2, 2023 |
Exhibit 99.7 CERTIFICATION PURSUANT TO 18 U.S.C. §1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Curaleaf Holdings, Inc. (the “Company”) on Form 40-F for the period ended December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Ed Kremer, Chief Financial Officer, certify, pursuan |
|
| May 2, 2023 |
Form 52-109F2R Certification of Refiled Interim Filings Exhibit 99.4 Form 52-109F2R Certification of Refiled Interim Filings This certificate is being filed on the same date that Curaleaf Holdings, Inc. (the “issuer”) has refiled interim financial report and interim MD&A for the interim period ended June 30, 2022 presented under IFRS. I, Ed Kremer, Chief Financial Officer of the issuer, certify the following: 1. Review: I have reviewed the interim fina |
|
| May 2, 2023 |
Exhibit 99.3 CURALEAF HOLDINGS, INC. Amended and Restated Management’s Discussion and Analysis of Financial Condition and Results of Operations As of and for the Three and Twelve Months Ended December 31, 2021 and 2020 As Amended and Restated (Expressed in Thousands United States Dollars Unless Otherwise Stated) Notice to Reader Curaleaf Holdings, Inc. (the “Company”, "Curaleaf" or the "Group") ha |
|
| May 2, 2023 |
CURALEAF HOLDINGS, INC. ANNUAL INFORMATION FORM Year ended December 31, 2022 May 1, 2023 Exhibit 99.1 CURALEAF HOLDINGS, INC. ANNUAL INFORMATION FORM Year ended December 31, 2022 May 1, 2023 TABLE OF CONTENTS EXPLANATORY NOTES 1 CORPORATE STRUCTURE 3 GENERAL DEVELOPMENT OF THE BUSINESS 4 BUSINESS OF THE COMPANY 10 UNITED STATES REGULATORY OVERVIEW 17 RISK FACTORS 24 DIVIDENDS 49 DESCRIPTION OF THE CAPITAL STRUCTURE 50 MARKET FOR SECURITIES AND TRADING PRICE AND VOLUME 52 ESCROWED SECU |
|
| May 2, 2023 |
Exhibit 99.7 CERTIFICATION PURSUANT TO 18 U.S.C. §1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Amendment No. 1 to Annual Report of Curaleaf Holdings, Inc. (the “Company”) on Form 40-F for the period ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Ed Kremer, Chief Financial Office |
|
| May 2, 2023 |
Exhibit 99.5 CURALEAF HOLDINGS, INC. Amended and Restated Unaudited Condensed Interim Consolidated Financial Statements As of and for the Three and Six Months Ended June 30, 2022 and 2021 (Expressed in Thousands United States Dollars Unless Otherwise Stated) Notice to Reader Curaleaf Holdings, Inc. (the “Company”, “Curaleaf” or the “Group”) now prepares its financial statements filed with the Cana |
|
| May 2, 2023 |
Exhibit 99.10 CURALEAF HOLDINGS, INC. Amended and Restated Management’s Discussion and Analysis of Financial Condition and Results of Operations As of and for the Three and Nine Months Ended September 30, 2022 and 2021 (Expressed in Thousands United States Dollars Unless Otherwise Stated) Notice to Reader Curaleaf Holdings, Inc. (the “Company”, “Curaleaf” or the “Group”) now prepares its financial |
|
| May 2, 2023 |
Exhibit 99.1 CURALEAF HOLDINGS, INC. Amended and Restated Unaudited Condensed Interim Consolidated Financial Statements As of and for the Three and Nine Months Ended September 30, 2022 and 2021 As Amended and Restated (Expressed in Thousands United States Dollars Unless Otherwise Stated) Notice to Reader Curaleaf Holdings, Inc. (the “Company”, "Curaleaf" or the "Group") has restated its audited an |
|
| May 2, 2023 |
Exhibit 99.3 CURALEAF HOLDINGS, INC. Management’s Discussion and Analysis of Financial Condition and Results of Operations As of and for the Years Ended December 31, 2022 and 2021 (Expressed in Thousands United States Dollars Unless Otherwise Stated) MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021 (Amounts in thou |
|
| May 2, 2023 |
Form 52-109F2R Certification of Refiled Interim Filings Exhibit 99.3 Form 52-109F2R Certification of Refiled Interim Filings This certificate is being filed on the same date that Curaleaf Holdings, Inc. (the “issuer”) has refiled interim financial report and interim MD&A for the interim period ended June 30, 2022 presented under IFRS. I, Matt Darin, Chief Executive Officer of the issuer, certify the following: 1. Review: I have reviewed the interim fin |
|
| May 2, 2023 |
Exhibit 99.2 CURALEAF HOLDINGS, INC. Amended and Restated Management’s Discussion and Analysis of Financial Condition and Results of Operations As of and for the Three Months Ended March 31, 2022 and 2021 As Amended and Restated (Expressed in Thousands United States Dollars Unless Otherwise Stated) Notice to Reader Curaleaf Holdings, Inc. (the “Company”, "Curaleaf" or the "Group") has restated its |
|
| May 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K/A (Amendment No. 1) REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May, 2023. Commission File Number: 333-249081 CURALEAF HOLDINGS, INC. (Exact Name of Registrant as Specified in Charter) 666 Burrard Street, Suite 1700, Vancouver, British C |
|
| May 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May, 2023. Commission File Number: 333-249081 CURALEAF HOLDINGS, INC. (Exact Name of Registrant as Specified in Charter) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8 Cana |
|
| May 2, 2023 |
CONSENT OF ANTARES PROFESSIONAL CORPORATION Exhibit 99.9 CONSENT OF ANTARES PROFESSIONAL CORPORATION We hereby consent to the incorporation by reference of: ● our report, dated May 1, 2023, on the consolidated financial statements of the Curaleaf Holdings, Inc. (the “Company”) and its subsidiaries, which comprise the consolidated balance sheet as at December 31, 2021 and the consolidated statements of operations, comprehensive income (loss) |
|
| May 2, 2023 |
CONSENT OF PKF O'CONNOR DAVIES, LLP Exhibit 99.8 CONSENT OF PKF O'CONNOR DAVIES, LLP We hereby consent to the incorporation by reference of: ● our report, dated May 1, 2023, on the consolidated financial statements of the Curaleaf Holdings, Inc. (the “Company”) and its subsidiaries, which comprise the consolidated balance sheet as at December 31, 2022 and the consolidated statements of operations, comprehensive income (loss), shareh |
|
| May 2, 2023 |
Exhibit 99.6 CERTIFICATION PURSUANT TO 18 U.S.C. §1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Curaleaf Holdings, Inc. (the “Company”) on Form 40-F for the period ended December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Matt Darin, Chief Executive Officer of the Company, |
|
| May 2, 2023 |
Exhibit 99.6 CURALEAF HOLDINGS, INC. Amended and Restated Management’s Discussion and Analysis of Financial Condition and Results of Operations As of and for the Three and Six Months Ended June 30, 2022 and 2021 (Expressed in Thousands United States Dollars Unless Otherwise Stated) 1 Notice to Reader Curaleaf Holdings, Inc. (the “Company”, “Curaleaf” or the “Group”) now prepares its financial stat |
|
| May 2, 2023 |
Form 52-109F2R Certification of Refiled Interim Filings Exhibit 99.4 Form 52-109F2R Certification of Refiled Interim Filings This certificate is being filed on the same date that Curaleaf Holdings, Inc. (the “issuer”) has refiled interim financial report and interim MD&A for the interim period ended September 30, 2022 presented under IFRS. I, Ed Kremer, Chief Financial Officer of the issuer, certify the following: 1. Review: I have reviewed the interim |
|
| May 2, 2023 |
Exhibit 99.2 CURALEAF HOLDINGS, INC. Amended and Restated Management’s Discussion and Analysis of Financial Condition and Results of Operations As of and for the Three Months Ended March 31, 2022 and 2021 (Expressed in Thousands United States Dollars Unless Otherwise Stated) Notice to Reader Curaleaf Holdings, Inc. (the “Company”, “Curaleaf” or the “Group”) now prepares its financial statements fi |
|
| May 2, 2023 |
Exhibit 99.1 CURALEAF HOLDINGS, INC. Amended and Restated Unaudited Condensed Interim Consolidated Financial Statements As of and for the Three Months Ended March 31, 2022 and 2021 (Expressed in Thousands United States Dollars Unless Otherwise Stated) Notice to Reader Curaleaf Holdings, Inc. (the “Company”, “Curaleaf” or the “Group”) now prepares its financial statements filed with the Canadian Se |
|
| May 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 40-F/A Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 40-F/A Amendment No. 1 ☐REGISTRATION STATEMENT PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 or ☒ANNUAL REPORT PURSUANT TO SECTION 13(a) OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 Commission File Number 333-249081 CURALEAF HOLDINGS, INC. (Exact name of Regis |
|
| May 2, 2023 |
Form 52-109F2R Certification of Refiled Interim Filings Exhibit 99.8 Form 52-109F2R Certification of Refiled Interim Filings This certificate is being filed on the same date that Curaleaf Holdings, Inc. (the “issuer”) has refiled interim financial report and interim MD&A for the interim period ended June 30, 2022 presented under US GAAP. I, Ed Kremer, Chief Financial Officer of the issuer, certify the following: 1. Review: I have reviewed the interim f |
|
| May 2, 2023 |
Form 52-109F2R Certification of Refiled Interim Filings EX-99.3 4 tm2313284d4ex99-3.htm EXHIBIT 99.3 Exhibit 99.3 Form 52-109F2R Certification of Refiled Interim Filings This certificate is being filed on the same date that Curaleaf Holdings, Inc. (the “issuer”) has refiled interim financial report and interim MD&A for the interim period ended March 31, 2022 presented under US GAAP. I, Matt Darin, Chief Executive Officer of the issuer, certify the foll |
|
| May 2, 2023 |
Form 52-109F2R Certification of Refiled Interim Filings Exhibit 99.7 Form 52-109F2R Certification of Refiled Interim Filings This certificate is being filed on the same date that Curaleaf Holdings, Inc. (the “issuer”) has refiled interim financial report and interim MD&A for the interim period ended June 30, 2022 presented under US GAAP. I, Matt Darin, Chief Executive Officer of the issuer, certify the following: 1. Review: I have reviewed the interim |
|
| May 2, 2023 |
Exhibit 99.5 CERTIFICATION I, Ed Kremer, certify that: 1. I have reviewed this annual report on Form 40-F of Curaleaf Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to |
|
| May 2, 2023 |
Exhibit 99.2 CURALEAF HOLDINGS, INC. Consolidated Financial Statements As of and for the Years Ended December 31, 2022 and 2021 (Expressed in Thousands United States Dollars Unless Otherwise Stated) Notice to Reader The Company has chosen to prepare its financial statements filed on SEDAR and EDGAR in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) begin |
|
| May 2, 2023 |
Exhibit 99.1 CURALEAF HOLDINGS, INC. Amended and Restated Unaudited Condensed Interim Consolidated Financial Statements As of and for the Three and Six Months Ended June 30, 2022 and 2021 As Amended and Restated (Expressed in Thousands United States Dollars Unless Otherwise Stated) Notice to Reader Curaleaf Holdings, Inc. (the “Company”, "Curaleaf" or the "Group") has restated its audited annual c |
|
| May 2, 2023 |
Exhibit 99.1 CURALEAF HOLDINGS, INC. Amended and Restated Unaudited Condensed Interim Consolidated Financial Statements As of and for the Three Months Ended March 31, 2022 and 2021 As Amended and Restated (Expressed in Thousands United States Dollars Unless Otherwise Stated) Notice to Reader Curaleaf Holdings, Inc. (the “Company”, "Curaleaf" or the "Group") has restated its audited annual consolid |
|
| April 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April, 2023. Commission File Number: 333-249081 CURALEAF HOLDINGS, INC. (Exact Name of Registrant as Specified in Charter) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8 Ca |
|
| April 26, 2023 |
Curaleaf Holdings, Inc. Investor Relations Exhibit 99.1 Curaleaf Holdings, Inc. Investor Relations Curaleaf to Report Fourth Quarter and Fiscal Year End 2022 Financial and Operational Results NEW YORK, April 26, 2023 / PRNewswire/ - Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that it will report its financial and operati |
|
| April 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April, 2023. Commission File Number: 333-249081 CURALEAF HOLDINGS, INC. (Exact Name of Registrant as Specified in Charter) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8 Ca |
|
| April 26, 2023 |
FORM 51-102F3 MATERIAL CHANGE REPORT EX-99.1 2 tm2313687d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 FORM 51-102F3 MATERIAL CHANGE REPORT Item 1 Name and Address of Company Curaleaf Holdings, Inc. ("Curaleaf" or the "Company") 420 Lexington Avenue Suite 2035 New York, New York 10170-0052 Item 2 Date of Material Change April 13, 2023, and April 17, 2023 Item 3 News Release News releases with respect to the nature and substance of the materi |
|
| April 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April, 2023. Commission File Number: 333-249081 CURALEAF HOLDINGS, INC. (Exact Name of Registrant as Specified in Charter) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8 Ca |
